Free Trial

TScan Therapeutics (TCRX) Institutional Ownership

→ Look Who Fired the World’s Richest Man (From Banyan Hill Publishing) (Ad)
Free TCRX Stock Alerts
$8.99
+0.98 (+12.23%)
(As of 05/14/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for TScan Therapeutics (NASDAQ:TCRX)

Current
Institutional Ownership
Percentage
82.83%
Number of
Institutional Buyers
(last 12 months)
9
Total
Institutional Inflows
(last 12 months)
$11.82M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$68.21K
Get TCRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling TScan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TCRX Institutional Buying and Selling by Quarter

TScan Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024 Vanguard Group Inc.1,808,152$14.36M0.0%+1.1%3.776%
5/10/2024 Tocqueville Asset Management L.P.212,200$1.69M0.0%N/A0.443%
4/17/2024 Cannon Global Investment Management LLC17,500$139K0.4%N/A0.037%
2/14/2024Pale Fire Capital SE21,573$126K0.0%+30.2%0.045%
2/12/2024 Letko Brosseau & Associates Inc.20,700$121K0.0%-36.1%0.043%
1/31/2024 abrdn plc200,000$1.17M0.0%N/A0.418%
11/14/2023Pale Fire Capital SE16,575$42K0.0%N/A0.035%
11/9/2023 Letko Brosseau & Associates Inc.32,400$83K0.0%N/A0.068%
8/15/2023BVF Inc. IL2,989,474$7.47M0.2%N/A12.338%
8/10/2023Monashee Investment Management LLC400,000$1M0.2%N/A1.651%
7/26/2023 Privium Fund Management B.V.15,825$40K0.0%N/A0.065%
5/10/2023 Simplify Asset Management Inc.546,916$1.15M0.2%N/A2.257%
2/15/2023Tang Capital Management LLC514,655$798K0.1%-7.8%2.137%
11/16/2022 Alphabet Inc.1,077,080$3.29M0.2%N/A4.482%
11/15/2022Tang Capital Management LLC557,915$1.70M0.2%-25.4%2.322%
11/4/2022Prudential Financial Inc.11,000$34K0.0%N/A0.046%
11/1/2022 Privium Fund Management UK Ltd15,825$48K0.1%N/A0.066%
5/17/2022RA Capital Management L.P.1,021,764$2.86M0.1%-18.6%4.299%
5/17/2022Hhlr Advisors LTD.669,513$1.88M0.0%-47.8%2.817%
4/26/2022 Marquette Asset Management LLC28,895$81K0.0%+33.7%0.122%
2/15/2022Deer Management Co. LLC1,245,505$5.61M0.1%N/A5.240%
2/15/2022Adage Capital Partners GP L.L.C.550,000$2.48M0.0%+10.8%2.314%
1/19/2022 Marquette Asset Management LLC21,618$97K0.0%N/A0.091%
11/16/2021Schonfeld Strategic Advisors LLC22,200$185K0.0%N/A0.093%
11/16/2021Wellington Management Group LLP139,566$1.16M0.0%N/A0.582%
11/15/2021RA Capital Management L.P.1,255,317$10.47M0.1%N/A5.238%
11/15/2021 Caas Capital Management LP75,000$626K0.0%N/A0.313%
11/12/2021DC Investments Management LLC35,563$297K0.6%N/A0.148%
11/12/2021DC Funds LP630,000$5.25M20.6%N/A2.629%
11/9/2021 BlackRock Inc.1,500,577$12.52M0.0%N/A6.261%
11/9/2021Monashee Investment Management LLC100,000$834K0.2%N/A0.417%
(Data available from 1/1/2016 forward)

TCRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TCRX shares?

During the previous two years, 16 institutional investors and hedge funds held shares of TScan Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($14.36M), BVF Inc. IL ($7.47M), Alphabet Inc. ($3.29M), RA Capital Management L.P. ($2.86M), Hhlr Advisors LTD. ($1.88M), Tocqueville Asset Management L.P. ($1.69M), and abrdn plc ($1.17M).Learn more on TCRX's institutional investors.

What percentage of TScan Therapeutics stock is owned by institutional investors?

82.83% of TScan Therapeutics stock is owned by institutional investors. Learn more on TCRX's institutional investor holdings.

Which institutional investors have been buying TScan Therapeutics stock?

Of the 13 institutional investors that purchased TScan Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2.99M), Alphabet Inc. ($1.08M), Simplify Asset Management Inc. ($546.92K), Monashee Investment Management LLC ($400K), Tocqueville Asset Management L.P. ($212.20K), abrdn plc ($200K), and Letko Brosseau & Associates Inc. ($32.40K).

How much institutional buying is happening at TScan Therapeutics?

Institutional investors have bought a total of 5,559,793 shares in the last 24 months. This purchase volume represents approximately $16.33M in transactions.

Which TScan Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold TScan Therapeutics stock in the last 24 months: Hhlr Advisors LTD. ($613.46K), RA Capital Management L.P. ($233.55K), Tang Capital Management LLC ($233.15K), and Letko Brosseau & Associates Inc. ($11.70K).

How much institutional selling is happening at TScan Therapeutics?

Institutional investors have sold a total of 1,091,861 shares in the last 24 months. This volume of shares sold represents approximately $3.09M in transactions.


Related Companies:
This page (NASDAQ:TCRX) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners
Did Intel Just Dethrone Nvidia?
Chaikin Analytics
Claim Your Complimentary Bitcoin Reward
Crypto Swap Profits
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Charles Payne Demystifies Options
Unstoppable Prosperity
Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way
Small Cap Sniper
Crypto Millionaire Says: “Buy This $11 AI Coin.”
InvestorPlace
The only AI company you should be looking at
Behind the Markets